HTS is a drug discovery technique that involves screening and evaluating a large number of biological modulators and effectors against a specific target. It is commonly utilised in toxicity investigations and stem cell research. It's used to analyse chemicals in the environment, medications, and formulations for in-depth toxicological review and the establishment of disease-associated and predictive toxicological pathways. Miniaturization can help uncover harmful substances early in the medication development process, saving a lot of money. High throughput screening has achieved widespread acceptance and has become a typical method of drug discovery in the pharmaceutical industry over the last two decades. In the long run, expanded use of the HTS approach in the field of toxicity will prove advantageous.High Throughput Screening (HTS) Market accounted for US$ 15.23 billion in 2020 and is estimated to be US$ 45.30 billion by 2030 and is anticipated to register a CAGR of 11.5%.

The report "High Throughput Screening Market, By Product and Services (Reagents & Assay Kits, Instruments, Consumables & Accessories, and Software and Services), By Technology (Cell-Based Assays, 2D Cell Culture, 3D Cell Culture (Scaffold-Based Technologies (Hydrogels, Inert Matrix, and Micropatterned Surfaces) and Scaffold-Free Technologies (Microplate, Hanging-Drop Plates, Ultra-Low Binding Plates, and Other Scaffold-Free Technologies)) Perfusion Cell Culture, Lab-On-A-Chip (LOC), Ultra-High-Throughput Screening, Bioinformatics, and Label-Free Technology), By Application (Target Identification & Validation, Primary and Secondary Screening, Toxicology Assessment, and Other Applications), By End User (Pharmaceutical And Biotechnology Companies, Academic and Government Institutes, Contract Research Organizations, and Other End User), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030’’

Key Highlights:

• Danaher Corporation (US) purchased General Electric Company's (Cytiva) biopharma division in 2020 to extend its footprint in the high-throughput screening sector.
• BioTek Instruments (US) was bought by Agilent Technologies, Inc. (US) in 2019 to extend its presence and expertise in cell analysis. This breakthrough further bolstered the company's position in the burgeoning fields of immuno-oncology and immunotherapy.
• Danaher Corporation (US) bought Labcyte Inc. (US) in 2019 to increase its footprint in the high-throughput screening market by expanding its liquid handling and laboratory automation business.

Analyst View:

Increased R&D spending by pharmaceutical and biotechnology businesses, technological developments in HTS, and the availability of government financing and venture capital investments are all driving market expansion. Emerging markets and expanding applications in bio sciences research are also likely to generate potential prospects for HTS market participants.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “High Throughput Screening Market, By Product and Services (Reagents & Assay Kits, Instruments, Consumables & Accessories, and Software and Services), By Technology (Cell-Based Assays, 2D Cell Culture, 3D Cell Culture (Scaffold-Based Technologies (Hydrogels, Inert Matrix, and Micropatterned Surfaces) and Scaffold-Free Technologies (Microplate, Hanging-Drop Plates, Ultra-Low Binding Plates, and Other Scaffold-Free Technologies)) Perfusion Cell Culture, Lab-On-A-Chip (LOC), Ultra-High-Throughput Screening, Bioinformatics, and Label-Free Technology), By Application (Target Identification & Validation, Primary and Secondary Screening, Toxicology Assessment, and Other Applications), By End User (Pharmaceutical And Biotechnology Companies, Academic and Government Institutes, Contract Research Organizations, and Other End User), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030”

Key Market Insights from the report:

High Throughput Screening (HTS) Market accounted for US$ 15.23 billion in 2020 and is estimated to be US$ 45.30 billion by 2030 and is anticipated to register a CAGR of 11.5%. The global high throughput screening market is segmented into product and services, technology, application, end user and, region.

• Based on Product and Services, High Throughput Screening (HTS) Market is segmented into Reagents & Assay Kits, Instruments, Consumables & Accessories, and Software and Services.
• Based on Technology, High Throughput Screening (HTS) Market is segmented into Cell-Based Assays, 2D Cell Culture, 3D Cell Culture (Scaffold-Based Technologies (Hydrogels, Inert Matrix, and Micropatterned Surfaces) and Scaffold-Free Technologies (Microplate, Hanging-Drop Plates, Ultra-Low Binding Plates, and Other Scaffold-Free Technologies)) Perfusion Cell Culture, Lab-On-A-Chip (LOC), Ultra-High-Throughput Screening, Bioinformatics, and Label-Free Technology.  
• Based on Application, High Throughput Screening (HTS) Market is segmented into Target Identification & Validation, Primary and Secondary Screening, Toxicology Assessment, and Other Applications. 
• Based on End-User, High Throughput Screening (HTS) Market is segmented into Pharmaceutical And Biotechnology Companies, Academic and Government Institutes, Contract Research Organizations, and Other End User. 
• By Region, the High Throughput Screening (HTS) Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Competitive Landscape & their strategies of High Throughput Screening (HTS) Market:

The key players operating the high throughput screening market involves Agilent Technologies Inc., Bio-Rad Laboratories Inc., Merck KGaA, Perkinelmer Inc., Thermo Fisher Scientific Inc., Danaher, Tecan Group, Axxam, Bio-Rad and Hamilton Company.  Prominent players operating in the target market are focusing on strategic partnerships as well as the launching of the products to gain a competitive edge in the target market.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

• Explains an overview of the product portfolio, including product development, planning, and positioning
• Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
• Detailed analysis of the market revenue over the forecasted period.
• Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
• Study on the segments that are anticipated to dominate the market.
• Study on the regional analysis that is expected to register the highest growth over the forecast period

To know more

Contact Us:

Sales

Prophecy Market Insights

  1 860 531 2701

Email- sales@prophecymarketinsights.com

Website- www.prophecymarketinsights.com